Table 1.
Baseline Characteristics of Study Population Stratified by Successful and Unsuccesful Pharmacological Cardioversion
| Variable | Whole Population (N=450) | Successful Cardioversion (N=314) | Unsuccessful Cardioversion (N=136) | P Value |
|---|---|---|---|---|
| Male sex | 212 (47.1%) | 143 (45.5%) | 69 (50.7%) | 0.311a |
| Age, y | 65.5±11.9 | 65.4±11.2 | 65.9±13.2 | 0.640b |
| Weight, kg | 82.2±16.2 | 83.8±17.1 | 75.2±11.3 | 0.422b |
| Arterial hypertension | 328 (72.9%) | 226 (72.0%) | 102 (75.0%) | 0.559a |
| Diabetes mellitus | 79 (17.6%) | 57 (18.2%) | 22 (16.2%) | 0.576a |
| CAD/PAD | 144 (32.4%) | 107 (34.1%) | 37 (27.2%) | 0.154a |
| Former TIA/stroke | 20 (4.4%) | 18 (5.7%) | 2 (1.5%) | 0.043a |
| LVEF, % | 52.7±9.1 | 52.7±9.4 | 52.7±8.4 | 0.951b |
| LVEF <50% | 66 (14.7%) | 49 (15.6%) | 17 (12.5%) | 0.235a |
| LAd, mm | 42.2±5.1 | 42.0±4.8 | 42.6±5.7 | 0.320b |
| TnT, pg/mL | 10 (7; 16) | 9 (7; 16) | 10 (7; 15) | 0.795c |
| SCr, mg/dL | 0.99±0.34 | 0.98±0.36 | 1.02±0.26 | 0.293b |
| eGFR, mL/min | 71.4±17.6 | 72.5±17.4 | 68.7±17.8 | 0.046b |
| eGFR <60 mL/min per 1.73 m2 | 105 (23.3%) | 69 (22.0%) | 36 (26.5%) | 0.261a |
| K+ level, mEq/L | 4.3±0.4 | 4.2±0.4 | 4.3±0.4 | 0.023b |
| WBC, ×1000/μL | 7.8±2.9 | 7.6±3.0 | 8.1±2.5 | 0.187b |
| Hemoglobin, g/dL | 14.3±1.5 | 14.3±1.5 | 14.3±1.5 | 0.729b |
| TSH, mIU/L | 1.81 (1.10–2.72) | 1.90 (1.10–2.72) | 1.55 (1.16–2.58) | 0.749c |
CAD indicates coronary artery disease; eGFR, estimated glomerular filtration rate; LAd, left atrial diameter; LVEF, left ventricular ejection fraction; PAD, peripheral artery disease; SCr, serum creatinine concentration; SD, standard deviation; TIA, transient ischemic attack; TnT, troponin T concentration; TSH, thyroid‐stimulating hormone concentration; WBC, white blood cell count.
a
Chi‐squared test.
b
Student t test.
c
Mann‐Whitney U test.